P—Peptide library
Growth hormone axis peptides
Growth-hormone-releasing peptides and secretagogues, from FDA-approved tesamorelin to unapproved research compounds. Most are prohibited in sport; WADA status is shown on each profile.
5 peptides
| Name | Type | Compounding | Categories | Evidence level | Ev. vs. Hype | Momentum | WADA | Reviewed | + |
|---|---|---|---|---|---|---|---|---|---|
| CJC-1295 | Research Only | Not cleared (advisory panel rejected) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| CJC-1295 + Ipamorelin Blend CJC/Ipa · CJC-Ipamorelin | Research Only | Not allowed (blends excluded) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Ipamorelin | Research Only | Not cleared (advisory panel rejected) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Tesamorelin Egrifta | FDA Approved | Approved product (not applicable) | Growth hormone axis | Human RCTs (approved use) | Evidence Hype | Steady | Prohibited | 2026-10-30 | |
| Tesamorelin + Ipamorelin Blend Tesa/Ipa | Research Only | Not allowed (blends excluded) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 |
Information only — not medical advice. Browse and filter the full peptide library.